News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Christine Hodgdon: CHLOE study enrolling participants with HER2+ oligometastatic breast cancer
Christine Hodgdon/leeoesterreich.org
Mar 16, 2025, 12:18

Christine Hodgdon: CHLOE study enrolling participants with HER2+ oligometastatic breast cancer

Christine Hodgdon, Co-founder of GRASP, shared a post on X:

“If you are living with HER2+ oligometastatic breast cancer (oligo = limited of mets), you may be eligible to participate in the CHLOE study, Yale Cancer Center.

Individuals (US and international) can now self refer!

Read more.”

More posts featuring Christine Hodgdon.

Breast Cancer cancer CHLOE study Christine Hodgdon HER2+ oligometastatic breast cancer OncoDaily Oncology Yale Cancer Center
Special Coverage
Science
Sep 3, 2025, 06:38
Hira Mian: Real-World Outcomes of 1,477 TIE Patients in Canada
Voices
Sep 3, 2025, 06:25
Collaborative Engagement with St. Francis Hospital Strengthens National Cancer Registry – National Cancer Institute of Kenya
Voices
Sep 3, 2025, 06:23
Health Information Technology in Breast Cancer Care - Ecancer
Voices
Sep 3, 2025, 06:15
Sumanta Pal: Congratulations to Cristiane D Bergerot on ASCO Global Guideline on Geriatric Assessment
Societies
Sep 3, 2025, 05:47
Join ESMO AI and Digital Oncology Congress 2025 - ESMO
Voices
Sep 2, 2025, 22:37
Tyler Seibert: How Much Can A GG2 Prostate Cancer Grow in 2 Months?
Societies
Sep 2, 2025, 22:03
European Liver Screening Week - European Liver Patients'​ Association
Science
Sep 2, 2025, 21:19
Mohamed Emam Sobeih: The Efficacy of Benson’s Relaxation Technique on Anorexia and Sleep in Cancer Patients
Voices
Sep 2, 2025, 20:50
Anton Gokin: Latest Updates in Oncology Market and Science
Science
Sep 2, 2025, 20:26
Yinghui Li: Novel lncRNA PLUM Drives Chemoresistance in Multiple Myeloma Through PRC2 Pathway
Societies
Sep 2, 2025, 18:53
A Busy Month of Global Healthcare Innovation and Conferences - EHFF
Voices
Sep 2, 2025, 18:26
Tong Yin Shared Details of AstraZeneca’s ECP Symposium on Breast Cancer Diagnostics